Novartis India Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 22,92,871 shares,. Its Average Traded Price (ATP) is ₹2458.78, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 5 @ ₹2428.20.
Novartis India has an upper circuit limit of ₹2671.00 and a lower circuit limit of ₹2185.40. The total value traded stands at ₹563.77 CR, and the delivery percentage for the day is 15.14%.
The stock is currently traded with a market lot size of 1. Novartis India also offers a dividend yield of 0%.
Novartis India Share Price Chart
Novartis India Share Key Metrics
Volume
22.93 L
Market Cap
5995.42 CR
LTQ@LTP
5@2428.20
ATP
2458.78
Var Margin
23.46 %
Circuit Range
2185.4-2671
Delivery %
15.14 %
Value
563.77 CR
ASM/GSM
No
Market Lot
1
Novartis India Resistance and Support
Pivot 2416.37
Resistance
First Resistance
2600.64
Second Resistance
2773.07
Third Resistance
2957.34
Support
First Support
2243.94
Second Support
2059.67
Third Support
1887.24
Novartis India Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Novartis India Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-23 | Quarterly Results |
| 2025-10-28 | Quarterly Results |
| 2026-05-12 | Audited Results |
| 2026-01-28 | Quarterly Results |
| 2025-07-29 | Quarterly Results |
| 2025-05-09 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
| 2024-10-25 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2025-07-23 | 2025-07-23 | View More |
Novartis India News
Novartis India Ltd - 500672 - Intimation Regarding The Acquisition Of Trademarks "Minipress" And "Minipres" From Pfizer Inc. USA And Pfizer Products Inc. USA, The Same Is Approved By The Board Of Directors Of The Company At Their Board Meeting Held Today I.E. September 07, 2026
Novartis has acquired the 'Minipress' and 'Minipres' trademarks along with related intellectual property from Pfizer Inc. USA for Rs. 1,250 crore. This strategic move aims to bolster Novartis's portfolio in the hypertension and BPH therapeutic areas, leveraging established brands.
Sep 07 2026 11:24:31
Novartis India Ltd - 500672 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company Held On August 17, 2026
Novartis India's Board of Directors approved a proposal to change the company's name and make consequential alterations to its Memorandum and Articles of Association. The board also approved a new Memorandum of Association to align with the Companies Act, 2013. Both resolutions require shareholder approval at the upcoming Annual General Meeting.
Aug 17 2026 19:51:24
Novartis India Management
| Name | Position |
|---|---|
| Chandni Maru | Company Secretary & Compliance Officer |
| Christopher Snook | Chairperson |
Novartis India Similar Stocks
Confidence Petroleum India Ltd.
87.84
0.00 (0.00%)
BLS E-Services Ltd.
316.60
0.00 (0.00%)
Navneet Education Ltd.
127.69
0.00 (0.00%)
Vimta Labs Ltd.
634.95
0.00 (0.00%)
EFC (I) Ltd.
188.04
0.00 (0.00%)
Vintage Coffee & Beverages Ltd.
176.93
0.00 (0.00%)
Flair Writing Industries Ltd.
238.54
0.00 (0.00%)
Medi Assist Healthcare Services Ltd.
323.05
0.00 (0.00%)
Fischer Medical Ventures Ltd.
34.90
0.00 (0.00%)
Mold-Tek Packaging Ltd.
685.45
0.00 (0.00%)
Novartis India FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in NOVARTIND
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC